ONCO Onconetix, Inc. Common Stock
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ONCO
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 2
- List Date
- 2022-02-18
- CIK
- 0001782107
- Next Earnings
- 2026-11-12
- Headquarters
- Cincinnati, OH
- Homepage
- https://www.onconetix.com
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -- | -2.10% | -16.42% | -11.80% | -10.11% |
| Feb | -- | -1.16% | -59.38% | -52.55% | -37.70% |
| Mar | -- | -16.40% | -69.11% | -54.16% | -46.56% |
| Apr | -- | -24.94% | -3.43% | -62.96% | -30.44% |
| May | -- | 78.46% | -0.13% | -81.10% | -0.92% |
| Jun | -- | -11.81% | -29.85% | -0.88% | -14.18% |
| Jul | -- | -1.27% | -24.26% | -24.85% | -16.79% |
| Aug | -- | -8.74% | -15.07% | -22.72% | -15.51% |
| Sep | -- | 0.93% | 6.14% | 19.84% | 8.97% |
| Oct | -- | -34.02% | 14.53% | -46.36%* | -21.95% |
| Nov | -- | -76.21% | -12.03% | -- | -44.12% |
| Dec | 4.21% | 2.94% | -40.91% | -- | -11.25% |
| Total | 4.21% | -85.96% | -97.12% | -99.50% | -69.59% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.58
SMA 50: $0.67
SMA 200: $15.48
Current: $0.40
EMA 12: $0.49
EMA 26: $0.58
MACD: -0.0949 | Signal: -0.0170
BEARISH
ADX (14): 14.38
RANGE
+DI: 27.50
−DI: 27.57
Momentum Oscillators
RSI (14): 32.70
NEUTRAL
Stoch %K: 5.84
Stoch %D: 7.25
Williams %R: -96.02
Volume & Volatility
BB Upper: $0.84
BB Lower: $0.31
NEUTRAL
OBV: 140,981,804
Vol SMA 20: 3,132,823
Vol ROC: -13.93%
ATR: $0.09
True Range: $0.04
HV 20: 128.8%
HV 30: 155.3%
HV 60: 152.3%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: ONCO
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers: Positive news sentiment, technical momentum signals, and beta analysis.
Primary risks: High volatility, negative news sentiment, and potential for technical breakdown.
Investment thesis: ONCO has been trending upwards due to a series of positive announcements and news headlines. The stock's high beta suggests it is more volatile than the market, but this can also be an opportunity for traders seeking higher returns. However, caution should be exercised due to the potential for sharp price movements.
Recent news sentiment impact: Positive news headlines have contributed to the stock's upward momentum, with recent announcements from Onconetix highlighting partnerships and product launches.
Technical Analysis
Trend Direction: Medium-term (1-3 months): Bullish
Support/Resistance Levels:
- Resistance: $0.98 (upper Bollinger band)
- Support: $0.74 (SMA 50)
Momentum Signals:
- RSI interpretation: Neutral (52.68), indicating no strong buying or selling pressure.
- MACD signal: Bearish, but with a neutral reading (-0.03 / Signal: 0.04 / Histogram: -0.07).
- Bollinger Bands position: Neutral, with the price touching the middle band.
Volume Analysis: High volume trend, indicating institutional interest and potential for further upward momentum.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines have dominated the past few months, highlighting partnerships, product launches, and company achievements.
Sentiment Assessment: Overall sentiment is positive, with 4 out of 6 recent headlines having a positive tone.
Catalyst Identification: Upcoming catalysts include potential earnings announcements and regulatory developments.
Market Narrative: News sentiment aligns with the technical analysis, suggesting a bullish trend. However, there may be some concern about the stock's high volatility.
Risk & Volatility Assessment
Beta Interpretation: High risk relative to market (beta: 1.28).
Volatility Regime: Current volatility is higher than historical levels (HV20: 157.4%, HV30: 147.4%).
Options Market Signals: No options data available.
Downside Protection: Support levels at $0.74 (SMA 50) and $0.50 (lower Bollinger band).
Market Context & Positioning
Sector Performance: ONCO is outperforming the market sector, with a relative strength of 1.21.
Institutional Activity: High institutional interest, as indicated by high volume trends.
Correlation Analysis: Correlation with the market is moderate (0.10).
Relative Valuation: ONCO is trading within its trading range, with some upside potential.
Key Levels & Action Items
Critical Price Levels:
- Resistance: $0.98
- Support: $0.74
Breakout/Breakdown Levels: Breakout above the upper Bollinger band ($0.98) or breakdown below the lower Bollinger band ($0.50).
Time-Sensitive Catalysts: Upcoming earnings announcements and regulatory developments.
Risk Management: Consider stop-loss levels at $0.74 (SMA 50) and position sizing considerations to manage risk.
Please note that this report is a sample output, and actual analysis may vary based on the specific data provided.
Generated
News
All ONCO news →
ONCO Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 0.9534
Alpha: -456.63%
Correlation: 0.0718
R-Squared: 0.5%
Stock Volatility: 169.1%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
ONCO Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
ONCO Insider Trading (Form 4)
Latest: 2026-04-22Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-04-22 | HRT FINANCIAL LP | 10%+ Owner | Sell (S) | −49,710 | $0.69 | -$34.3K | EDGAR |
| 2026-04-21 | HRT FINANCIAL LP | 10%+ Owner | Mixed | −113,693 | $0.74 | -$84.9K | EDGAR |
| 2026-04-16 | HRT FINANCIAL LP | 10%+ Owner | Buy (P) | +166,904 | $0.76 | $127.6K | EDGAR |
| 2025-08-19 | Andrew John Oakley | Director | Mixed | +638 | — | EDGAR | |
| 2025-08-19 | Timothy R. Ramdeen | Director | Mixed | +657 | — | EDGAR | |
| 2025-08-19 | Thomas Meier | Director | Mixed | +657 | — | EDGAR | |
| 2025-08-19 | Simon Tarsh | Director | Mixed | +657 | — | EDGAR | |
| 2025-07-16 | Altos Venture AG | 10%+ Owner | Other (J) | +241,514 | — | EDGAR | |
| 2025-03-25 | Andrew John Oakley | Director | Award (A) | +1,709 | — | EDGAR | |
| 2025-01-22 | Ralph Schiess | Interim CEO, CSO | Award (A) | +177,462 | — | EDGAR | |
| 2025-01-22 | Christian Bruhlmann | Chief Strategy Officer | Award (A) | +177,462 | — | EDGAR | |
| 2024-09-30 | Thomas Meier | Director | Award (A) | +3,318 | — | EDGAR | |
| 2024-09-30 | Simon Tarsh | Director | Award (A) | +3,318 | — | EDGAR | |
| 2024-09-30 | Timothy R. Ramdeen | Director | Award (A) | +3,318 | — | EDGAR | |
| 2024-09-30 | Ajit Singh | Director | Award (A) | +3,318 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ONCO Insider Holdings
8 insiders · @ $0.40
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Altos Venture AG | 10%+ Owner | 5,465 | $2.2K | $0 | 1 | 2025-07-16 |
| 2 | HRT FINANCIAL LP | 10%+ Owner | 3,365 | $1.3K | $8.4K | 3 | 2026-04-22 |
| 3 | Ralph Schiess | Interim CEO, CSO | 158 | $63 | $0 | 2 | 2025-01-22 |
| 4 | Christian Bruhlmann | Chief Strategy Officer | 144 | $57 | $0 | 2 | 2025-01-22 |
| 5 | Timothy R. Ramdeen | Director | 13 | $5 | $0 | 2 | 2025-08-19 |
| 6 | Thomas Meier | Director | 13 | $5 | $0 | 2 | 2025-08-19 |
| 7 | Andrew John Oakley | Director | 13 | $5 | $0 | 2 | 2025-08-19 |
| 8 | Simon Tarsh | Director | 1 | $0 | $0 | 2 | 2025-08-19 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ONCO Board & Officers
As of SEC filings through Apr 22, 2026Directors 3
- Simon Tarsh · since Aug 22, 2022
- Sarah Romano · since Dec 5, 2025
- Sammy Dorf · since Mar 19, 2026
Officers 1
- David Allan White · Chief Executive Officer · since Mar 18, 2026
10% owners 1
- Altos Venture AG (entity) · since Sep 24, 2024
Changes in the last 10 years (51)
| Apr 22, 2026 | Hrt Financial LP reported in an SEC filing no longer being a 10% owner |
| Apr 20, 2026 | The company announced the departure of Thomas Meier from the board in an SEC filing |
| Apr 20, 2026 | The company announced the departure of Andrew John Oakley from the board in an SEC filing |
| Apr 14, 2026 | Hrt Financial LP became a 10% owner |
| Mar 19, 2026 | The company announced the departure of Timothy R. Ramdeen from the board in an SEC filing |
| Mar 19, 2026 | Sammy Dorf became a director |
| Mar 18, 2026 | David Allan White became Chief Executive Officer |
| Dec 5, 2025 | Sarah Romano became a director |
| Aug 6, 2025 | The company announced the departure of Ajit Singh from the board in an SEC filing |
| Feb 24, 2025 | The company announced the departure of James Sapirstein from the board in an SEC filing |
| Feb 24, 2025 | Andrew John Oakley became a director |
| Feb 18, 2025 | The company announced the departure of Christian Bruhlmann as Chief Strategy Officer in an SEC filing |
| Sep 26, 2024 | Ralph Schiess listed as Interim CEO & CSO (previously Chief Science Officer) in SEC filings |
| Sep 24, 2024 | Altos Venture AG became a 10% owner |
| Jun 10, 2024 | Karina M Fedasz became Interim CFO |
| Jun 8, 2024 | The company announced the departure of Bruce Harmon as Chief Financial Officer in an SEC filing |
| Feb 8, 2024 | Ajit Singh became a director |
| Feb 6, 2024 | Thomas Meier became a director |
| Jan 10, 2024 | The company announced the departure of Neil J Campbell from the board in an SEC filing |
| Jan 10, 2024 | The company announced the departure of Neil J Campbell as Chief Executive Officer in an SEC filing |
| Dec 21, 2023 | The company announced the departure of Erin Henderson as Chief Business Officer in an SEC filing |
| Dec 15, 2023 | Ralph Schiess became Chief Science Officer |
| Dec 15, 2023 | Christian Bruhlmann became Chief Strategy Officer |
| Oct 4, 2023 | The company announced the departure of Jon Garfield as CFO in an SEC filing |
| Oct 4, 2023 | Neil J Campbell became a director |
| Oct 4, 2023 | Neil J Campbell became Chief Executive Officer |
| Oct 4, 2023 | Bruce Harmon became Chief Financial Officer |
| Sep 2, 2023 | The company announced the departure of Vuk Jeremic from the board in an SEC filing |
| Aug 16, 2023 | The company announced the departure of Joseph Hernandez from the board in an SEC filing |
| Aug 16, 2023 | The company announced the departure of Joseph Hernandez as CEO in an SEC filing |
| Apr 12, 2023 | Cincinnati Cornerstone Investors BWV I, LLC reported in an SEC filing no longer being a 10% owner |
| Jan 13, 2023 | Timothy R. Ramdeen became a director |
| Jan 13, 2023 | The company announced the departure of Kimberly M Murphy from the board in an SEC filing |
| Nov 4, 2022 | Vuk Jeremic became a director |
| Nov 4, 2022 | The company announced the departure of Michael Venerable from the board in an SEC filing |
| Aug 29, 2022 | Cincinnati Cornerstone Capital LLC no longer listed as a 10% owner in SEC filings |
| Aug 23, 2022 | Allan Shaw reported in an SEC filing no longer being a director |
| Aug 22, 2022 | Simon Tarsh became a director |
| May 27, 2022 | Joseph Hernandez first listed as a director in an SEC filing |
| May 27, 2022 | Jon Garfield first listed as a director in an SEC filing |
| Feb 23, 2022 | James Sapirstein became a director |
| Feb 17, 2022 | Michael Venerable became a director |
| Feb 17, 2022 | Kimberly M Murphy became a director |
| Feb 17, 2022 | Joseph Hernandez became a 10% owner |
| Feb 17, 2022 | Joseph Hernandez became CEO |
| Feb 17, 2022 | Jon Garfield became CFO |
| Feb 17, 2022 | John McCune Rice Jr. became a director |
| Feb 17, 2022 | Erin Henderson became Chief Business Officer |
| Feb 17, 2022 | Cincinnati Cornerstone Investors BWV I, LLC became a 10% owner |
| Feb 17, 2022 | Cincinnati Cornerstone Capital LLC became a 10% owner |
| Feb 17, 2022 | Allan Shaw became a director |
Not reported recently (5)
- Ralph Schiess · Last reported as Interim CEO & CSO in an SEC filing dated Jan 22, 2025
- Karina M Fedasz · Last reported as Interim CFO in an SEC filing dated Jun 20, 2024
- Joseph Hernandez · Last reported as a 10% owner in an SEC filing dated May 11, 2023
- Jon Garfield · Last reported as a director in an SEC filing dated May 27, 2022
- John McCune Rice Jr. · Last reported as a director in an SEC filing dated Feb 17, 2022
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.